InsiderTrades.com logo
All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle
From Investing Trends   |   Ad
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
Look At This Under-The-Radar Lithium Company

MXCT Insider Trading (MaxCyte)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £222,400
Insider Selling (Last 12 Months): £625,135

MaxCyte Insider Trading History Chart

This chart shows the insider buying and selling history at MaxCyte by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MaxCyte Share Price & Price History

Current Price: GBX 700
Price Change: ▼ Price Decrease of -18 (-2.51%)
As of 11/29/2021 06:08 PM ET

This chart shows the closing price history over time for MXCT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
From All Marijuana Stocks   |   Ad
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1 Stock

MaxCyte Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Richard DouglasInsiderBuy20,000GBX 1,112£222,400
2/18/2021Will BrookeInsiderSell40,900GBX 1,015£415,135
2/3/2021Stark ThompsonInsiderSell30,000GBX 700£210,000
10/1/2020Stark ThompsonInsiderSell25,000GBX 355£88,750
3/19/2019Stark ThompsonInsiderSell25,000GBX 180£45,000
See Full Table
Insider Buying at MaxCyte?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for MaxCyte and related companies.

SEC Filings (Institutional Ownership Changes) for MaxCyte (LON:MXCT)

MaxCyte logo
MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally. Its transfection systems include MaxCyte STX, a scalable transfection system that uses flow electroporation technology for the engineering of cells for a range of applications; MaxCyte VLX, an instrument for large volume cell-engineering; and MaxCyte GT, a non-viral cell-engineering technology designed for clinical use. The company also provides single use sterile processing assemblies; and proprietary electroporation buffers; and ExPERT brand series of instruments and consumables, as well as insourcing services. In addition, it develops CARMA, a novel and proprietary technology for the development of non-viral, human messenger RNA-based, chimeric antigen receptor or T-cell receptor redirected immune cell therapies. The company licenses and sells its instruments and technology; and sells its products to drug developers and biopharmaceutical companies. It has a clinical and commercial license agreement with Allogene Therapeutics, Inc. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Read More on MaxCyte

Today's Range

Now: GBX 700
Low: 690
High: 730

50 Day Range

MA: GBX 901.29
Low: 680
High: 1,223

52 Week Range

Now: GBX 700
Low: 380
High: 1,235

Volume

73,415 shs

Average Volume

184,115 shs

Market Capitalization

£705.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MaxCyte?

MaxCyte's top insider investors include:
  1. Richard Douglas (Insider)
  2. Stark Thompson (Insider)
  3. Will Brooke (Insider)
All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle
From Investing Trends   |   Ad
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
Look At This Under-The-Radar Lithium Company